atrial fibrillation, persistent, non valvular, stroke, ischemic, cerebral infarction, embolic
DISEASE INTERVENTION COMPARISON RESULTS
JAMA. 2005 Feb 9;293(6):690-8 Randomized Controlled Trial, Multicenter Study
IN atrial fibrillation, persistent, non valvular, stroke, ischemic, cerebral infarction, embolic The Use of
anticoagulants, direct thrombin inhibitors, ximelagatran
As Treatment, Chronic
Is equal Than
warfarin
To prevent, at 20 months, stroke (of any type): 1.6% xime. VS 1.2% warf. Elevated liver enzymes (>3N): 6% xime. VS 0.8% warf. Major and minor bleeding combined fewer with xime. (37%) than warf. (47%) but not major bleeding alone.